InNexus (TSX: IXS / OTCBB: IXSBF) Signs on Immunology Specialist
Drug development company InNexus Biotechnology Inc. (TSX: IXS / OTCBB: IXSBF) made headlines today when it announced that Dr. Ellen S. Vitetta, an expert in immunological research, has joined the company's newly formed Scientific Advisory Board.According to the company's latest press release, Dr. Vitetta will join such fine minds as Dr. J. Donald Capra, president emeritus of the Oklahoma Medical Research Foundation; InNexus SAB Chairman Dr. Thomas Kindt; Dr. John D. Minna, professor and director of the Hamon Center for Therapeutic Oncology Research at UT Southwestern Medical Center at Dallas; and Dr. Carlos L. Arteaga, vice chancellor's chair in Breast…